ArticlePloS one2026

Cost-effectiveness of semaglutide versus dulaglutide for Type 2 Diabetes in China: A Markov Model analysis.

Qiying Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.